85 related articles for article (PubMed ID: 3308159)
21. Plasmodium vivax: a monoclonal antibody recognizes a circumsporozoite protein precursor on the sporozoite surface.
Gonzalez-Ceron L; Rodriguez MH; Wirtz RA; Sina BJ; Palomeque OL; Nettel JA; Tsutsumi V
Exp Parasitol; 1998 Nov; 90(3):203-11. PubMed ID: 9806864
[TBL] [Abstract][Full Text] [Related]
22. Detection of antigens in the urine of patients with acute Plasmodium vivax malaria.
Militão DN; Camargo LM; Katzin AM
Exp Parasitol; 1993 Mar; 76(2):115-20. PubMed ID: 8454019
[TBL] [Abstract][Full Text] [Related]
23. Antigenic disparity of Plasmodium vivax causing initial symptoms and causing relapse.
Khusmith S; Tharavanij S; Bunnag D
Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):519-24. PubMed ID: 10437949
[TBL] [Abstract][Full Text] [Related]
24. Targets of protective antibodies to malaria during pregnancy.
Beeson JG; Rogerson SJ; Elliott SR; Duffy MF
J Infect Dis; 2005 Nov; 192(9):1647-50. PubMed ID: 16206081
[No Abstract] [Full Text] [Related]
25. [Diagnosis of malaria with immunochromatographic test The Novara experience].
Garavelli PL
Recenti Prog Med; 2002 Dec; 93(12):682. PubMed ID: 12587607
[TBL] [Abstract][Full Text] [Related]
26. Antibody responses of patients with natural malaria to human and simian plasmodium antigens measured by the fluorescent antibody test.
Meuwissen JH
Trop Geogr Med; 1968 Jun; 20(2):137-40. PubMed ID: 4968381
[No Abstract] [Full Text] [Related]
27. Evaluation of a rapid diagnostic test specific for Plasmodium vivax.
Kim SH; Nam MH; Roh KH; Park HC; Nam DH; Park GH; Han ET; Klein TA; Lim CS
Trop Med Int Health; 2008 Dec; 13(12):1495-500. PubMed ID: 18983278
[TBL] [Abstract][Full Text] [Related]
28. [Malaria vaccine research].
Sellioğlu B
Mikrobiyol Bul; 1986 Jan; 20(1):37-41. PubMed ID: 3523172
[TBL] [Abstract][Full Text] [Related]
29. [A longitudinal survey of malaria by using the indirect fluorescent antibody test (IFAT)].
Huang WZ
Zhonghua Liu Xing Bing Xue Za Zhi; 1986 Aug; 7(4):212-5. PubMed ID: 3539356
[No Abstract] [Full Text] [Related]
30. Malaria antibody titres as measured by the indirect fluorescent antibody test in relation to parasitaemia and treatment.
Pillay MR; Frank H; Ponnampalam JT
Southeast Asian J Trop Med Public Health; 1981 Mar; 12(1):111-3. PubMed ID: 7020094
[TBL] [Abstract][Full Text] [Related]
31. [Application of the indirect immunofluorescence test to seroepidemiological surveys of malaria--results of indirect fluorescent antibody test of malaria from several different types of endemic areas (author's transl)].
Wu KC
Zhonghua Yu Fang Yi Xue Za Zhi; 1979; 13(3):129-35. PubMed ID: 400288
[No Abstract] [Full Text] [Related]
32. [A study of monoclonal antibody ELISA test to detect malaria parasite antigens].
Yang CX; Gao Q; Wang XR; Zhan WQ; Lou GX
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1987; 5(4):248-50. PubMed ID: 3329991
[No Abstract] [Full Text] [Related]
33. The epidemiologic interpretation of serologic data in malaria.
Draper CC; Voller A; Carpenter RG
Am J Trop Med Hyg; 1972 Sep; 21(5):696-703. PubMed ID: 4561518
[No Abstract] [Full Text] [Related]
34. Cross-reactivity studies of an anti-Plasmodium vivax apical membrane antigen 1 monoclonal antibody: binding and structural characterisation.
Igonet S; Vulliez-Le Normand B; Faure G; Riottot MM; Kocken CH; Thomas AW; Bentley GA
J Mol Biol; 2007 Mar; 366(5):1523-37. PubMed ID: 17229439
[TBL] [Abstract][Full Text] [Related]
35. [The mechanisms of acquired immunity in infections with Plasmodium vivax. Fluorescent antibody technics in the complex of cyto-sero-chemical tests of the blood system during the process of immunogenesis].
Bona C; Ciplea AG; Ianco L; Negulici EB; Constantinesco P
Arch Roum Pathol Exp Microbiol; 1964 Sep; 23(3):749-62. PubMed ID: 5318885
[No Abstract] [Full Text] [Related]
36. Plasmodium vivax malaria in Sri Lanka: transmission, disease and immunity.
Carter R; David P; Mendis K
Parassitologia; 1993 Jul; 35 Suppl():17-8. PubMed ID: 8233604
[TBL] [Abstract][Full Text] [Related]
37. The seroepidemiology of malaria in Middle America. V. Antibody responses in an indicator population from an endemic area with attack phase antimalaria activities.
Warren M; Collins WE; Jeffery GM; Skinner JC
Am J Trop Med Hyg; 1983 Nov; 32(6):1209-15. PubMed ID: 6359903
[TBL] [Abstract][Full Text] [Related]
38. [Use of serological methods in a system of measures for the epidemiological surveillance of malaria (a review of the literature)].
Suleĭmanov GD
Med Parazitol (Mosk); 1982; 51(6):63-7. PubMed ID: 6759903
[No Abstract] [Full Text] [Related]
39. Antibodies to Plasmodium vivax apical membrane antigen 1: persistence and correlation with malaria transmission intensity.
Morais CG; Soares IS; Carvalho LH; Fontes CJ; Krettli AU; Braga EM
Am J Trop Med Hyg; 2006 Oct; 75(4):582-7. PubMed ID: 17038677
[TBL] [Abstract][Full Text] [Related]
40. IgG antibody profile to c-terminal region of Plasmodium vivax merozoite surface protein-1 in Thai individuals exposed to malaria.
Pitabut N; Panichakorn J; Mahakunkijcharoen Y; Hirunpetcharat C; Looareesuwan S; Khusmith S
Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):1-7. PubMed ID: 17539238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
